You are here

  • Home
  • Archive
  • Volume 10, Issue 6
  • Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis

Article info

Article menu
Clinical care/Education/Nutrition
Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis

Authors

  • Annika Grönberg Department of Women's and Children's Health, Uppsala Universitet Institutionen for kvinnors och barns halsa, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Daniel Espes Department of Medical Sciences, Uppsala University, Uppsala, SwedenScience for Life Laboratory, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Per-Ola Carlsson Department of Medical Sciences, Uppsala University, Uppsala, SwedenScience for Life Laboratory, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Johnny Ludvigsson Department of Biomedical and Clinical Scienses, Linkopings Universitet, Linkoping, Sweden PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Annika Grönberg; annika.gronberg{at}kbh.uu.se
View Full Text

Citation

Grönberg A, Espes D, Carlsson P, et al
Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
BMJ Open Diabetes Research and Care 2022;10:e002991. doi: 10.1136/bmjdrc-2022-002991

Publication history

  • Received June 16, 2022
  • Accepted October 18, 2022
  • First published November 16, 2022.
Online issue publication 
November 16, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.